HAOHAI BIOTEC (06826): Completed Repurchase of 1.8324 Million A-Shares

Stock News
08/15

HAOHAI BIOTEC (06826) announced the results of its second phase A-share repurchase program. As of August 14, 2025, the company has completed the current repurchase phase. Through the Shanghai Stock Exchange's centralized bidding trading system, the company has cumulatively repurchased 1.8324 million A-shares, representing 0.79% of the company's total share capital. The highest transaction price during the repurchase was 63.58 yuan per share, while the lowest price was 49.25 yuan per share, with an average repurchase price of 56.70 yuan per share. The total amount paid reached 103.9 million yuan (excluding stamp duty, transaction commissions and other fees).

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10